To help independent pharmacy owners better understand the fast-growing, uber-complex specialty pharmacy business, the National Community Pharmacists Association last month hosted a day-long forum, “Exploring the intersection of specialty medications, community pharmacy and patient care.”
There are more than 100 million people over the age of 50 who are responsible for at least $7.1 trillion in annual economic activity – a figure that is expected to reach well over $13.5 trillion in real terms by 2032, according to Oxford Economics.
Pager is looking to become the “Amazon of healthcare.” That’s what co-founder Oscar Salazar told CNBC during a recent interview to discuss telehealth, as well as Hillary Clinton’s statements on the economy and jobs.
Congress, Medicare and industry stakeholders should strike the right balance to cut out fraud in the Medicare Part D drug program while preserving patient access to critical medications, the National Community Pharmacists Association stated in comments submitted in conjunction with a House Energy and Commerce subcommittee hearing Tuesday on the topic.
America’s biopharmaceutical research companies are currently developing 420 medicines for patients suffering from neurological disorders, including epilepsy, Alzheimer’s disease, multiple sclerosis and Parkinson’s disease.
On the occasion of the 2015 White House Conference on Aging, which marks the sixth such event since the first in 1961, National Association of Chain Drug Stores president and CEO Steve Anderson joined the dialogue by issuing a statement.
How hard is it to find $24 billion to offset the cost of repealing the medical device tax? As hard as it is “to find a cup of coffee at Starbucks.” That’s according to National Center for Policy Analysis senior fellow John R. Graham, in a Forbes commentary.
Otsuka Pharmaceutical and H. Lundbeck A/S announced Friday that their new medication Rexulti (brexpiprazole) had been approved by the Food and Drug Administration as an adjunctive treatment for major depressive disorder (MDD) and a treament for schizophrenia.